Sam Faulkner is a Consultant with The RSA Group, a global leader in Life Sciences Executive Search and Executive interims. Based at the firm’s Welwyn Garden City office, Sam works closely with local leadership teams across Executive Search and Executive Interims to drive business efforts in the UK.
Sam has spent the last seven years working as a Consultant at Just Pharma, where he initiated and developed relationships with clients across the pharmaceutical, CRO and medical technology industries in Western European countries and The United States. As a recruiter Sam has a generalist background, which has enabled him to adapt within diversified fields and to quickly understand his client’s needs.
Sam holds a management degree from the University of Derby. Following his graduation, Sam lived and worked in New Zealand, until he later returned to the UK.
Insight, perspective and opinion in the RSA blog from Mark.
Mark Howard is a Managing Partner with The RSA Group, a global leader in Life Sciences Executive Search and Executive Interims. With a focus on biotech and specialty pharma, Mark leads the firm’s search activity and consultants in EMEA.
In healthcare recruitment since 1995, Mark has developed a substantial reputation for providing talent solutions to a range of organisations in the pharmaceutical, biotech, medical devices,CXO and not-for-profit sectors. With experience in commercial, scientific and general management roles, his industry breadth brings substantial value to clients. Mark has led searches for talent and leadership in disciplines ranging from discovery research to clinical development to finance to human resources.
Mark gained executive search experience in several boutique search providers and global firms before joining The RSA Group. With substantial leadership experience in the recruitment industry, Mark has worked internationally and has developed successful teams placing talent sourced globally. In addition, he has established operations in the UK, Africa and in the Asia Pacific Region.
A qualified marketer, Mark began his career in the FMCG sector, where he held senior sales and marketing positions, developed consumer brands, and build successful relationships with major clients.
Insight, perspective and opinion in the RSA blog from Mark.
Mark Johnson is a Partner with The RSA Group, a leader in Life Sciences Executive Search and Executive Interims. A respected search professional with a background in science and the pharmaceutical industry, clients view Mark as a trusted ambassador for their companies. His dedication and consistent work demonstrates the difference that the right appointment can make to a firm.
Partnering with biopharmaceutical companies from start-up through to global multinational organisations, Mark is experienced in building out leadership, management and technical teams. Throughout his career, Mark has recruited across the leadership spectrum from C-suite to technical experts, with experience in medical, manufacturing and supply chain, commercial, R&D, CMC, Clinical Operations, Regulatory and Programme / Project Leaders. Most recently Mark has had a strong concentration in Cell and Gene Therapy and is now considered to be an expert in this talent field by his clients.
Mark’s industry experience comes from his earlier career in biologics at MedImmune and Novartis. Here he worked in development, manufacturing and quality for vaccine products that ultimately made the transition to full global release.
Mark holds a BSc in Applied Biology from Liverpool John Moores University.
Kristian Jürgensen returned to RSA as Managing Partner in May 2019. Based in Frankfurt, Basel and London, he works closely with the global leadership team to deliver the best value to our clients.
Prior to returning to RSA in 2019, he was a Partner in two global Executive Search firms and has over 18 years of consulting experience.
Kristian returned to RSA the 2nd time in July 2012 as Managing Director after working for two years as Head of Tender Management for a mid-sized German Generics company. He was responsible for handling incoming tenders which included but was not limited to scouting API vendors and CMO globally, managing the business of the SCM, Regulatory and Quality departments.
Before joining the Generics industry Kristian was Director of RSA Interims in Germany, where he built a successful Interim Management business and managed a strong team of Consultants.
Kristian is a qualified lawyer certified in pharmaceutical law and he holds an MBA. He is fluent in German and English.
Graham Kilbey is a Chartered Accountant with over 30 years’ experience in corporate tax and financial matters.
He started his career with KPMG and then spent over 25 years advising international companies on their tax affairs. Companies include: Arcadia Group, Alliance Boots, AB InBev, Balfour Beatty, Sky, Dixons and Tesco. During that period, Graham also appeared as an expert witness on behalf of HMRC in a leading tax avoidance case.
Graham was the original advisor to Roger Stephens Associates when it was founded in 1981 and joined the Board in 2001.
Apart from RSA, Graham is also a non-executive director of Capital Physio Limited and a Member Nominated Trustee Director of the Arcadia Senior Executive Pension Scheme.
Insight, perspective and opinion in the RSA blog from Prad.
Business Development Director
Prad is a highly successful Business Developer within the Pharmaceutical and Healthcare sector with over 26 years of experience selling sales force solutions to clients across UK, EU, USA and Asia.
With a proven ability to deliver against sales targets, he has a wealth of experience in joint decision making at client board level, an excellent track record of sales success and the ability to motivate delivery teams towards company and client goals.
Prad now provides executive Interims to Healthcare & Pharmaceutical clients across all Commercial functions to include General Management, Regulatory, Operations, Medical, Marketing & Brand/Product Managers
Shawn O’Connor is a Managing Partner with The RSA Group, a leader in Life Sciences Executive Search and Executive Interims. Based in the firm’s New Jersey office, Shawn leads The RSA Group’s efforts in North America.
An accomplished search consultant, Shawn has over 10 years of experience establishing and leading executive search teams, with a proven track record of success. He brings to The RSA Group a deep understanding of pharmaceuticals, biotechnology, diagnostics and medical devices, covering functions from R&D to sales and marketing. In addition, his corporate experience has been invaluable in allowing him to truly understand and consult with clients’ needs and challenges.
Throughout his career, Shawn worked extensively to lead and drive business successes with a particular focus on the alignment of senior management teams, succession planning, recruiting strategies and executive development. He’s partnered with a wide scope of life sciences firms, from early-stage companies to large multinational corporations in the recruitment of senior executives and structuring of global teams.
Prior to working in executive search, Shawn spent almost 20 years at Johnson & Johnson, where he was Vice President, Human Resources. Additionally, he has significant corporate experience with other Fortune 50 companies, including Kraft and GE.
Shawn holds a degree in Human Resources Management as well as graduate studies in Organizational Psychology from Columbia University.
Insight, perspective and opinion in the RSA blog from Kristin.
I joined RSA in January 2016. I have five years experience working at two different major quoted, international recruitment companies. Recently I have been working in Switzerland for companies within the life science industry, mainly pharma companies, biotech and medical devices, as well as CROs and CMOs. My clients ranged from innovative start-ups to small and medium sized enterprises up to international headquarters of leading companies.
I mainly focused on positions in regulatory affairs, clinical, health economics, market access, pricing & reimbursement as well as biometrics including biostatistics, SAS programming and clinical data management. Before joining the recruitment industry I worked for an international pharmaceutical wholesaler.
I studied international business management and gained international experience working and studying in the UK, Switzerland and Spain, as well as in the US.
Besides my native German language, I also speak English.
Insight, perspective and opinion in the RSA blog from Thomas.
Thomas Schleimer is a Managing Partner with The RSA Group, a global leader in Life Sciences Executive Search and Executive interims. Based between the firm’s London, Frankfurt and Basel offices, Thomas works closely with local leadership teams to drive business efforts within EMEA, specifically the DACH region.
An experienced international executive, Thomas brings over 30 years of life sciences sector experience to The RSA Group. With a focus on the medtech and biopharma sectors, Thomas has a strong track record in the placement of C-suite leadership and board directors.
Prior to joining executive search, Thomas held a series of senior leadership positions in the medical device, pharmaceutical and biotech industries with responsibilities at Director, VP and Managing Director level. Notable roles include Business Unit Director for Nordics at Cephalon (Teva) in Copenhagen, and Regional Managing Director for Smiths Medical, responsible for business in the UK, Ireland, Nordics, Australia and New Zealand. In 2013 he led a successful MBO of an executive search consultancy which was sold in 2016.
Thomas holds a master’s degree in International Business Administration and Languages from the University of Lund, Sweden and has completed the Advanced Management & Executive Education Programmes at the Stockholm School of Economics (AMP). A Swedish national, he is fluent in English, German and Scandinavian Languages and has lived in the UK since 2003.
Insight, perspective and opinion in the RSA blog from Andy .
Andy Smith is a Partner with The RSA Group, a leader in Life Sciences Executive Search and Executive Interims. Based in the firm’s Singapore office, Andy has over 15 years’ search experience dedicated to the Life Sciences sector, and brings an Asia-Pacific knowledge and focus to the RSA team.
Andy’s experience includes the placement of executives from senior technical specialist to 'C' level across the sector, including biotechnology, specialty pharma, big pharma, medical devices, diagnostics, generics, biosimilars, academic institutions, consumer healthcare, consultancy and other related service providers. His functional expertise covers most management disciplines, including general management, clinical research, business development, human resources, research & development, medical, marketing & sales, manufacturing, IT and, finance.
Beginning his search career in London, Andy has since spent significant periods of time based in EMEA, Asia Pacific and North America. Most recently, he served as a Director in a boutique Life Sciences firm in Asia Pacific. Before this, Andy was in-house Global Search Consultant at AbbVie - a major global biopharmaceutical company – where he developed and executed search strategies for senior regional and global executive positions.
Having spent over 10 years living and working across regions, Andy has a unique understanding of the careful management needed in projects involving cross-border moves of executives.
Insight, perspective and opinion in the RSA blog from Nick.
Nick Stephens is Executive Chair of The RSA Group, a global leader in Life Sciences Executive Search and Executive Interims. Serving biotech, pharma, medical devices, diagnostic, and academic medical research markets. The RSA Group specialises in C-suite, senior executive and board level searches. His company has developed unique “Data Driven Due Diligence” methodologies that minimise risk and maximise upside in building and developing leadership teams and Boards.
Over more than three decades he and his company have helped to build hundreds of companies which have brought new therapies to patients everywhere. His daily conversations with industry leaders across the world have brought him unique insights into what works where and, perhaps more importantly what will add risk. He believes that with the right people in place patients will have quicker access to better medicines.
Nick is a law graduate with broad commercial experience in various roles spanning metals trading, medical devices, pharmaceuticals and the British National Health Service.
He has been a Director of The RSA Group since 1986, joined the business full-time in 1995 and took it over in 2000. Nick also serves as an Independent Non-Executive Director of an investment company focusing on cannabinoid and Internet-of-Things businesses; an early stage biotech company with a proprietary platform in oncology, anti-infectives and diagnostics, an Oxford University Alzheimer’s Biotech Spin Out, an IT business specializing in healthcare, travel and cybersecurity and an advanced AgriTech business.
Insight, perspective and opinion in the RSA blog from Dr. Andy.
Dr. Andy Theodorou
Dr. Andy Theodorou is a Senior Consultant with The RSA Group, a global leader in Life Sciences Executive Search and Executive interims.
Andy brings a unique profile to executive search, combining a strong and relevant academic and research background in Neuropharmacology with 18 years executive search experience gained within leading global organisations.
Working across most functions in the life sciences sector, Andy has placed senior level executives across most functions: from discovery research to clinical development, commercial and general management. He has a particular focus in R&D, Bioinformatics, Data Sciences and market access.
Andy has extensive knowledge and interest in a number of Therapeutic Areas, particularly in Oncology and Neurosciences which has enabled him to build a global network of professional contacts working in these areas.
Andy holds a BSc and PhD in Pharmacology and is a member of the British Pharmacological Society. He continues to have a keen interest in education, learning and development and to this end he is a trustee of a Primary Academy.
Business Development Director
Phil has over 30 years experience in the Pharmaceutical, Healthcare and Biotech Industries. Over this time Phil has built an in depth understanding and experience of building successful sales teams, developing commercial solutions and supporting organisations at all stages i.e. in their set up, their launch plans and sales optimisation. Phil has a focused and efficient approach to achieving success and is passionate about delivering high quality service.
His network of contacts and reputation in the industry is second to none and as a result Phil is able to quickly find the right solutions for his Clients.
Phil now provides executive Interims to Healthcare & Pharmaceutical clients across all commercial functions including General Management, Regulatory, Operations, Medical, Marketing & Brand/Product Managers.
Natalie is a Corporate Partner in the life sciences practice at Covington, a leading global law firm and as such she has immense experience advising Boards of UK, European and global life science companies.
Natalie frequently works with FTSE and Nasdaq listed companies and her professional expertise has been recognised many times, most recently as ‘Best in Capital Markets’ at Euromoney’s ‘Europe Women in Business Law’ awards.
Insight, perspective and opinion in the RSA blog from Dafydd.
Dafydd Wright is a Managing Partner with RSA Interims, a proven leader in Life Sciences Executive interims. Heading up the business unit that he’s help to build out from The RSA Group, Dafydd manages the global interims business and consultants.
An award winning leader in interim management, Dafydd favours a people-oriented, consultative approach focusing on interim management as a solution rather than a fill in. He feels strongly that interim management provides the opportunity to add an additional layer of expertise, enabling organisations to move faster and achieve their goals. Since 2007, Dafydd has dedicated his efforts to building the value of the interims model across the life sciences industry.
Previously, Dafydd worked in the diagnostics industry as a research scientist. He has a degree in Applied Microbiology and has worked and lived in the UK and Finland.